Product Images Montelukast Sodium

The figure shows the change in height (cm) from the randomization visit by scheduled week for three treatment groups: Nontelukast 5 mg (n=120), Beclomethasone 336 meg (n=119), and Placebo (n=121). The standard errors of the treatment group means in change in height are too small to be visible on the plot.*

This is a chart showing the mean percent change from baseline in FEV over 15 weeks of treatment with Montelukast Sodium or Placebo in a U.S. Trial. The chart was analyzed using ANOVA model. The x-axis shows the weeks in treatment, including a washout phase, and the y-axis shows the mean percent change from baseline.*

Rising® Montelukast is a medication available in the form of chewable tablets containing 5.19 mg of montelukast sodium USP, equivalent to 5 mg of montelukast. It is prescribed for pediatric patients aged 6 to 14 years. The medication guide should be dispensed to each patient by the pharmacist. It contains phenylalanine and should be kept away from children. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) and protected from moisture and light. Distributed by Rising Health, LLC, it is made in India. The code for the medication is TS/DRUGS/22/2009, revised in May 2020.*

Rising® is a medication containing 30 tablets of Montelukast Sodium USP, with a dosage for adults of 15 years and older. Each film-coated tablet contains 10.38 mg of Montelukast Sodium, equivalent to 10 mg of Montelukast. It is necessary to dispense the medication guide separately to each patient. The usual dosage depends on the prescribing information. The tablets should be stored in the original package, protected from moisture and light at 20° to 25°C (68° to 77°F) in a USP Controlled Room Temperature. This drug has been distributed by Rising Health, LLC located in Saddle Brook, NJ 07663 and was made in India. Last revised in May 2020.*